Comments from Dr. Shefali Agarwal, President and CEO, on Brain Delivery Module Platform Agreement with Novartis
July 10, 2025
Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets
July 09, 2025
Sironax Accelerates Global Expansion
June 30, 2025
Sironax Story | Build the Bridge From Bench to Bedside for Degenerative Diseases
May 08, 2025
Sironax Completed Phase I study for SIR2501
April 22, 2025
Sironax Celebrates US Team Expansion And China IND Approvals
Mar 31, 2025
Sironax Announces Closing of $200M Series B Financing
Aug 02, 2022
